We found that the ELTD1 expression levels in the tumors were significantly higher than those in normal brains, especially in high-grade glioma (III + IV), by analyzing the bioinformatics data (Fig. 1A–D, P < 0. Here, ADGRL4 is linked to central nervous system cancer.